DE3879853D1 - Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien. - Google Patents

Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.

Info

Publication number
DE3879853D1
DE3879853D1 DE8888309387T DE3879853T DE3879853D1 DE 3879853 D1 DE3879853 D1 DE 3879853D1 DE 8888309387 T DE8888309387 T DE 8888309387T DE 3879853 T DE3879853 T DE 3879853T DE 3879853 D1 DE3879853 D1 DE 3879853D1
Authority
DE
Germany
Prior art keywords
composition
active substance
medicinal products
substance release
controlled active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888309387T
Other languages
English (en)
Other versions
DE3879853T2 (de
Inventor
Chi-Long Lee
Katherine Lynn Ulman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Corp
Original Assignee
Dow Corning Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Corp filed Critical Dow Corning Corp
Application granted granted Critical
Publication of DE3879853D1 publication Critical patent/DE3879853D1/de
Publication of DE3879853T2 publication Critical patent/DE3879853T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A61L15/585—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/61—Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/81—Unsaturated isocyanates or isothiocyanates
    • C08G18/8108—Unsaturated isocyanates or isothiocyanates having only one isocyanate or isothiocyanate group
    • C08G18/8116—Unsaturated isocyanates or isothiocyanates having only one isocyanate or isothiocyanate group esters of acrylic or alkylacrylic acid having only one isocyanate or isothiocyanate group
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06—Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/08—Saturated oxiranes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J183/00—Adhesives based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Adhesives based on derivatives of such polymers
    • C09J183/04—Polysiloxanes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J183/00—Adhesives based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Adhesives based on derivatives of such polymers
    • C09J183/10—Block or graft copolymers containing polysiloxane sequences
    • C09J183/12—Block or graft copolymers containing polysiloxane sequences containing polyether sequences
DE88309387T 1987-10-15 1988-10-07 Klebstoffzusammensetzung, Zusammensetzung mit kontrollierter Wirkstofffreisetzung und System zur transdermalen Anwendung von Arzneien. Expired - Fee Related DE3879853T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/109,157 US4898920A (en) 1987-10-15 1987-10-15 Adhesive compositions, controlled release compositions and transdermal delivery device

Publications (2)

Publication Number Publication Date
DE3879853D1 true DE3879853D1 (de) 1993-05-06
DE3879853T2 DE3879853T2 (de) 1993-10-21

Family

ID=22326113

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88309387T Expired - Fee Related DE3879853T2 (de) 1987-10-15 1988-10-07 Klebstoffzusammensetzung, Zusammensetzung mit kontrollierter Wirkstofffreisetzung und System zur transdermalen Anwendung von Arzneien.

Country Status (7)

Country Link
US (1) US4898920A (de)
EP (1) EP0312265B1 (de)
JP (1) JPH0699678B2 (de)
CA (1) CA1321849C (de)
DE (1) DE3879853T2 (de)
DK (1) DK575388A (de)
FI (1) FI93223C (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5209924A (en) * 1989-08-07 1993-05-11 Minnesota Mining And Manufacturing Company Polysiloxane-grafted copolymer topical binder composition with novel fluorochemical comonomer and method of coating therewith
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
CA2106465A1 (en) * 1991-03-20 1992-09-21 Mieczyslaw H. Mazurek Radiation-curable acrylate/silicone pressure sensitive adhesive compositions
JPH06506014A (ja) * 1991-03-20 1994-07-07 ミネソタ　マイニング　アンド　マニュファクチャリング　カンパニー 放射線硬化性ビニル／シリコーン剥離コーティング
US5455279A (en) * 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine
US6071876A (en) * 1991-04-19 2000-06-06 Children's Medical Center Corporation Method of preventing NMDA receptor complex-mediated neuronal damage
US5227169A (en) * 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5308887A (en) * 1991-05-23 1994-05-03 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesives
US5464659A (en) * 1991-05-23 1995-11-07 Minnesota Mining And Manufacturing Company Silicone/acrylate vibration dampers
US5232838A (en) * 1991-12-09 1993-08-03 Minnesota Mining And Manufacturing Company Culture media device and method of use
US6162456A (en) * 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE4414837A1 (de) * 1994-04-28 1995-11-23 Kettenbach Fabrik Chem Erzeugn Haftvermittlerschicht für Zahnprothesenunterfütterungen und Verfahren zu ihrer Herstellung
US5612400A (en) * 1995-06-06 1997-03-18 General Electric Company Silicone pressure sensitive adhesive compositions and method for making
ES2190472T5 (es) * 1995-06-07 2012-03-09 Ortho-Mcneil Pharmaceutical, Inc. Parche transdérmico para la administración de 17-deacetil norgestimato, en combinación con un estrógeno.
GB9607897D0 (en) * 1996-04-17 1996-06-19 Dow Corning Sa Organosiloxane compositions
US6391999B1 (en) * 1998-02-06 2002-05-21 Rensselaer Polytechnic Institute Epoxy alkoxy siloxane oligomers
US6124376A (en) * 1998-08-24 2000-09-26 Xerox Corporation Ink composition for ink jet printing
EP1109594B1 (de) 1998-08-31 2004-10-27 Johnson & Johnson Consumer Companies, Inc. Elektrotransportvorrichtung mit klingen
WO2000062857A1 (en) 1999-04-16 2000-10-26 Johnson & Johnson Consumer Companies, Inc. Electrotransport delivery system comprising internal sensors
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
EP1207843A2 (de) * 1999-08-26 2002-05-29 Basf Aktiengesellschaft Kosmetische und/oder pharmazeutische zubereitungen enthaltend polysiloxanhaltige polymerisate und deren verwendung
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
WO2005021058A2 (en) 2003-09-02 2005-03-10 Coloplast A/S Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers
JP5160217B2 (ja) * 2004-03-12 2013-03-13 ダウ・コーニング・コーポレイション シリコーンポリエーテルを使用する、親水性薬剤供給用シリコーン感圧接着剤を調製する方法
US20070149916A1 (en) * 2005-12-22 2007-06-28 Alza Corporation Dry matrices as drug reservoirs in electrotransport applications
KR100821561B1 (ko) * 2006-11-17 2008-04-15 한국전자통신연구원 유비쿼터스 센서 네트워크를 이용한 소음 및 진동 관리방법 및 시스템
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
CN102947370B (zh) 2010-04-23 2016-05-11 汉高知识产权控股有限责任公司 硅酮-丙烯酸共聚物
DE102011100619A1 (de) 2010-05-05 2012-01-05 Amw Gmbh Transdermales therapeutisches System (TTS) mit einem Gehalt an einem Opiod-Analgetikum
US9399123B2 (en) 2012-01-04 2016-07-26 Momentive Performance Materials Inc. Silicone adhesive compositions
EP3663372B1 (de) * 2018-12-06 2024-03-13 Henkel AG & Co. KGaA Härtbare zusammensetzung mit polysiloxan-polyalkylenglycol-bürstencopolymeren
EP3663371B1 (de) 2018-12-06 2024-03-13 Henkel AG & Co. KGaA Herstellung von polysiloxan-polyalkyleneglycol-bürsten-copolymeren

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25727E (en) 1965-02-09 Organosiloxane ethers
US25727A (en) * 1859-10-11 Wheelwright-machine
US2736721A (en) * 1952-10-08 1956-02-28 Optionally
US2814601A (en) * 1954-04-29 1957-11-26 Dow Corning Organopolysiloxane adhesive and pressure-sensitive adhesive tape containing same
US2868824A (en) * 1956-08-09 1959-01-13 Dow Corning Polymeric organosiloxanes
US3057469A (en) * 1958-11-24 1962-10-09 Minnesota Mining & Mfg Silicones
FR1361668A (fr) * 1962-08-09 1964-05-22 Dow Corning Composition organosiloxane adhésive améliorée sensible à la pression
GB1058159A (en) * 1964-09-14 1967-02-08 Ici Ltd Organosilicon polymers
GB1133273A (en) * 1965-12-07 1968-11-13 Gen Electric Siloxane-oxyalkylene copolymer and use thereof
US3387061A (en) * 1966-05-04 1968-06-04 Union Carbide Corp Chemical reaction product of polycarboxylic acid and a polymeric polyether
US3528940A (en) * 1966-12-15 1970-09-15 Gen Electric Silicone pressure-sensitive adhesive of improved strength
US3734097A (en) * 1969-04-01 1973-05-22 Alza Corp Therapeutic adhesive tape
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3527842A (en) * 1969-04-14 1970-09-08 Dow Corning Pressure sensitive adhesive made from siloxane resins
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
US3965150A (en) * 1970-12-18 1976-06-22 General Electric Company Polyether esters of alkenoic acids
US3957843A (en) * 1971-03-30 1976-05-18 Union Carbide Corporation Non-isomerizable olefinic polyoxyalkylene polymers and siloxane-polyoxyalkylene copolymer derivatives thereof
US3731683A (en) * 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3819745A (en) * 1972-03-27 1974-06-25 Dow Corning Coatings giving controlled release
US3983298A (en) * 1975-04-18 1976-09-28 Dow Corning Corporation Polyorganosiloxane pressure sensitive adhesives and articles therefrom
CA1106993A (en) * 1976-05-26 1981-08-11 Martin M. Sackoff Method for making a pressure sensitive adhesive coated laminate
US4235988A (en) * 1976-12-13 1980-11-25 Imperial Chemical Industries Limited Delivery means for biologically active agents
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4460371A (en) * 1981-11-24 1984-07-17 Dennison Manufacturing Company Silicone pressure sensitive adhesive and uses
CA1218954A (en) * 1982-02-25 1987-03-10 David L. Sieverding Hydrophilic, elastomeric, pressure-sensitive adhesive
JPS5936608A (ja) * 1982-08-23 1984-02-28 Hisamitsu Pharmaceut Co Inc 新規貼付薬
JPS5936609A (ja) * 1982-08-26 1984-02-28 Nitto Electric Ind Co Ltd 粘着性貼付製剤
JPS5971377A (ja) * 1982-10-15 1984-04-23 Kanegafuchi Chem Ind Co Ltd 粘着剤組成物
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
US4591622A (en) * 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US4600751A (en) * 1984-12-18 1986-07-15 Dow Corning Corporation Hydrophilic silicone-organic copolymer elastomers
CA1257727A (en) * 1984-12-18 1989-07-18 Chi-Long Lee Hydrophilic silicone-organic copolymer elastomers
US4584337A (en) * 1984-12-18 1986-04-22 Dow Corning Corporation Aqueous emulsions containing hydrophilic silicone-organic copolymers
DE3502928A1 (de) * 1985-01-30 1986-07-31 Bayer Ag, 5090 Leverkusen Neue polysiliconblockcopolymere
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
JPH0699678B2 (ja) 1994-12-07
FI93223C (fi) 1995-03-10
DK575388D0 (da) 1988-10-14
JPH02658A (ja) 1990-01-05
FI884764A (fi) 1989-04-16
CA1321849C (en) 1993-08-31
FI884764A0 (fi) 1988-10-14
DE3879853T2 (de) 1993-10-21
EP0312265A3 (en) 1990-06-27
DK575388A (da) 1989-04-16
EP0312265B1 (de) 1993-03-31
FI93223B (fi) 1994-11-30
US4898920A (en) 1990-02-06
EP0312265A2 (de) 1989-04-19

Similar Documents

Publication Publication Date Title
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DE3685094D1 (de) Pharmazeutisches praeparat zur kontrollierten freisetzung von wirkstoffen.
DE3773057D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimitteln, ihre zubereitung und verwendung.
DE69107946D1 (de) Adhäsive Präparation zur Förderung der Regenierung verletzter Nerven und klebende pharmazeutische Zubereitungen dafür.
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
DE3762480D1 (de) Mittel zur applikation von transdermal resorbierbaren wirkstoffen.
NO871774L (no) Medikament-system med kontrollert frisettelse av det aktive middel.
DE69203990T2 (de) Einrichtung zur transdermalen Verabreichung von Medikamenten.
DE3587518T2 (de) Vorrichtung zur transdermalen Applikation von Medikamenten.
BR8404409A (pt) Composicao e dispositivo para a liberacao controlada e uniforme de um medicamento,agente bioativo ou semelhante
DE69118526T2 (de) Mittel zur transdermalen penetration von arzneimitteln
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
CS553490A3 (en) Transdermal therapeutic system
DE59006461D1 (de) Therapeutisches System zur verzögerten und gesteuerten transdermalen oder transmucosalen Verabreichung von Wirkstoffen (II).
DE3787377D1 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
DE3580283D1 (de) Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
DE3880212D1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
LU88849I2 (fr) Climara
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
DE3876756D1 (de) Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe.
DE3788852D1 (de) Proteine mit Glutathion-S-Transferase-Aktivität, DNA-Sequenzen, Antikörper, Poxviren und Arzneimittel zur Prävention von Schistosomiasis.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
DE59101214D1 (de) Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee